StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
FBIO

Fortress Biotech, Inc.

FBIOP Nasdaq Pharmaceutical Preparations EDGAR ↗
$18.98
+0.18 +0.96%

Key statistics

from XBRL data in SEC filings
Market cap
$729M
Revenue (TTM)
$66.2M
Net income (TTM)
$158M
EPS (TTM)
$3.23
P/E ratio
5.9
Dividend yield
Free cash flow
Cash
$256M
Total assets
$357M
Gross margin
52-week range
$6.27 – $21.43

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jun 23, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release) Mar 31, 2026 8-K Other events Mar 30, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Other events Feb 23, 2026 8-K Other events Jan 13, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Dec 15, 2025 8-K Other events Dec 15, 2025 8-K Other events Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 8-K Other events Oct 1, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Other events Jul 16, 2025 8-K Shareholder vote results Jun 23, 2025 8-K Completed an acquisition or disposition Jun 5, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 8-K Director or officer change Apr 16, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Entered a material agreement Mar 10, 2025 8-K Other events Jan 16, 2025 8-K Other events Jan 6, 2025 8-K Other events Dec 16, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Other events Nov 4, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Sep 23, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jul 25, 2024 8-K Entered a material agreement Jul 19, 2024 8-K Other events Jul 5, 2024 8-K Unregistered sale of equity Jun 28, 2024 8-K Amended charter or bylaws Jun 25, 2024 8-K Director or officer change; Shareholder vote results May 29, 2024